Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From RIBOMIC, Inc.
A busy stretch of deal-making across Asia all includes transactions involving Innovent, Alector, Ono, Numab, Alphamab, 3DMed, Healios, Athersys, Laekna, Novartis, Asahi Kasei, SBI Biotech, Glenmark, Hindustan Unilever, Hanlim, Alteogen, Ildong, Evotec, AJU Pharm, Ribomec, Tyligand, Context
One in and one out at Takeda’s European and Canada business unit while J&J appoints an outsider to head its consumer health business in Japan. Personnel changes also take place at Xinrong Best Medical Instrument following significant investment from Blackstone.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced August-September 2014.
- Antisense, Oligonucleotides
- Drug Discovery Tools
- Large Molecule
Drug Discovery Tools
- Molecular Diversity